A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout
Clinical trial NCT06229145 · COMPLETED
Trial details
- NCT number
- NCT06229145
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-18
- Primary completion
- 2025-07-30
- Enrollment
- 262
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.